Skip to main content

Table 1 Demographic and clinical characteristics of the study groups

From: Diagnostic significance of serum FGD5-AS1 and its predictive value for the development of cardiovascular diseases in patients with type 2 diabetes

Characteristics gender

Healthy subjects (n  = 100)

T2DM without CVDs (n  = 100)

P value (healthy subjects vs T2DM without CVDs)

T2DM with CVDs (n  = 100)

P value (healthy subjects vs T2DM with CVDs)

P value (T2DM without CVDs vs T2DM with CVDs)

Male (n)

55

50

0.481

55

0.778

0.324

Age (years)

52.9 ± 6.9

54.3 ± 10.1

0.266

52.7 ± 10.0

0.865

0.200

BMI (kg/m2)

26.9 ± 2.7

28.5 ± 3.3

0.000

29.4 ± 3.3

0.000

0.036

Current smokers, n

29

32

0.651

35

0.366

0.651

Systolic blood pressure (mmHg)

121.3 ± 4.9

132.7 ± 8.3

0.000

139.8 ± 11.3

0.000

0.000

Diastolic blood pressure (mmHg)

75.2 ± 8.3

85.1 ± 9.0

0.000

93.2 ± 8.1

0.000

0.000

Fasting glucose (mmol/L)

4.6 ± 0.48

6.70 ± 0.9

0.000

8.1 ± 1.1

0.000

0.000

2-h postprandial blood glucose (mmol/L)

5.6 ± 0.9

8.5 ± 0.8

0.000

10.0 ± 1.7

0.000

0.000

HbA1c (%)

4.8 ± 0.5

6.1 ± 0.7

0.000

7.8 ± 0.9

0.000

0.000

Triglycerides (mmol/L)

1.2 ± 0.1

1.6 ± 0.2

0.000

2.1 ± 0.4

0.000

0.000

HDL-cholesterol (mmol/L)

1.3 ± 0.1

1.1 ± 0.2

0.000

1.0 ± 0.2

0.000

0.000

LDL-cholesterol (mmol/L)

3.2 ± 0.6

3.3 ± 0.6

0.348

4.1 ± 0.7

0.000

0.000

usCRP (mg/L)

2.8 ± 0.8

4.3 ± 1.8

0.000

6.1 ± 1.7

0.000

0.000

  1. T2DM type 2 diabetes mellitus; CVDs cardiovascular disease; BMI body-mass index; HDL-cholesterol high-density lipoprotein cholesterol; LDL-cholesterol low-density lipoprotein cholesterol; usCRP ultra-sensitive C-reactive protein